New study aims to improve heart testing accuracy for valve disease

NCT ID NCT07112391

Recruiting now Knowledge-focused Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study involves 70 adults with severe heart valve disease who are already scheduled for a routine heart catheterization. Researchers will use special catheters to measure how well the right side of the heart works with the lungs. The goal is to see if simpler, non-invasive tests like ultrasound can give the same information, which could help doctors avoid invasive procedures in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could improve how doctors use ultrasound to assess heart function in valve disease patients, reducing the need for invasive catheter procedures.
What could go wrong: This is an observational study with no treatment being tested. It may not lead to immediate clinical changes, and results might not apply to all heart disease patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart disorder heart failure mitral valve insufficiency pulmonary valve insufficiency pulmonary valve stenosis tricuspid valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE INTERVENTIONAL CARDIOLOGY STRUCTURAL HEART DISEASE

Contacts and locations

Locations

CHU of NANTES
RECRUITING

Nantes, Loire Atlantique, 44000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.